Director
Roberta F. White, PhD, ABPP/cn, is Professor and Chair of EH at BUSPH and Professor of Neurology (Neuropsychology) at BUSM. She is a licensed clinical psychologist who is board certified in clinical neuropsychology and an Attending Psychologist at BMC. She is best known for her work in behavioral toxicology, where she has conducted research across the lifespan on the central nervous system effects of a wide variety of toxicants as well as the development of behavioral outcome and imaging measurements for exposure effect studies. She has also worked in neurogenetics and studies of dementia in the Framingham Heart Study and other populations. Her work is highly interdisciplinary, cutting across psychology, neurology, epidemiology, environmental health, exposure assessment, geriatrics and child development. She has trained over 70 doctoral students and post-doctoral fellows and has over 150 publications.
Deputy Director
David H. Sherr, PhD, is Professor of Environmental Health at BUSPH and Professor of Pathology at BUSM. Since 1993, David Sherr’s laboratory has used cutting edge technologies including molecular biology, cellular biology, and advanced imaging techniques to conduct research on how common environmental pollutants suppress development of a competent immune system. Dr. Sherr also conducts studies related to the molecular mechanisms through which environmental chemicals initiate and maintain breast cancer. These studies focus on the role of an environmental chemical receptor, the aryl hydrocarbon receptor (AhR), in deregulated tumor cell growth, resistance to death signals and in promoting breast cancer invasion. A third area of investigation centers on the use of molecular and computational technologies to identify tumor-associated proteins (e.g. AhR, CYP1B1, Blimp, and immunoglobulin light chains) for vaccination against several types of cancer, especially B cell malignancies. Dr. Sherr is a member of the BUSM Immunology Training Program, the Amyloid Treatment and Research Program, the Hematology/Oncology Training Program, and the Women’s Health Interdisciplinary Research Center. He directs the Boston University Medical Campus Flow Cytometry Core Facility, which services over 300 users throught the medical campus, and he has published over 96 articles in peer-reviewed journals including the Journal of Immunology, Journal of Experimental Medicine, Nature, Nature Genetics, Blood, Molecular Pharmacology, and Cancer Research. To learn more about Dr. Sherr's work, look here.